stomach cancer Archives

Study seeks to reverse precancerous stomach lesions

May. 4, 2017—Vanderbilt University Medical Center cancer researcher James Goldenring, M.D., Ph.D., has received a two-year, $200,000 grant from the DeGregorio Family Foundation in Pleasantville, New York, to begin clinical trials of a potential approach for reversing precancerous stomach lesions.

A DARPP role in gastric cancer

Nov. 3, 2016—Vanderbilt researchers have discovered a link between Helicobacter pylori infection, inflammation and gastric cancer that could suggest new anti-cancer therapies.

Stomach cancer cues

Aug. 6, 2015—Vanderbilt scientists have discovered a new molecular mechanism that promotes stomach cancer development, findings that could provide new opportunities for treatment.

Host sequesters zinc to control stomach bug

Nov. 21, 2014—Understanding how zinc and the host’s immune response control H. pylori’s cancer-causing potential could suggest new therapeutic strategies to reduce infection and cancer risk.

Therapeutic target for gastric cancer

Dec. 12, 2013—A protein kinase linked to inflammation and tumor development may be a good target for gastric cancer therapies.

Cell changes en route to stomach cancer

Sep. 26, 2013—Molecular characterization of pre-cancerous changes in cells lining the stomach could point to lesions with a greater risk of progression to cancer.

Noninvasive test detects stomach bug

Aug. 12, 2013—A noninvasive test can be used to identify the presence of Helicobacter pylori and evaluate its virulence, which will be useful in areas with high rates of H. pylori-associated gastric cancer.

Berlin earns stomach cancer foundation award

May. 30, 2013—Jordan Berlin, M.D., professor of Medicine and Ingram Professor of Cancer Research at Vanderbilt-Ingram Cancer Center, has received the Tree of Life award from Debbie’s Dream Foundation: Curing Stomach Cancer (DDF).

Salt revs stomach bug’s cancer impact

May. 13, 2013—A high-salt diet worsens the carcinogenic effects of Helicobacter pylori, a bacterium that colonizes the stomachs of half of the world’s population.